Published in Vet Pathol on March 01, 1978
Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun (1993) 3.34
The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect Immun (1993) 3.03
Locus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens. Infect Immun (2001) 2.68
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun (1999) 2.50
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun (2004) 2.32
Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun (2003) 2.22
The ultrastructure of transmissible murine colonic hyperplasia. Am J Pathol (1979) 2.11
Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun (2004) 1.95
Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev (1998) 1.88
Genetic and biochemical characterization of Citrobacter rodentium sp. nov. J Clin Microbiol (1995) 1.81
Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect Immun (1996) 1.76
Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect Immun (2002) 1.73
Citrobacter rodentium, the causative agent of transmissible murine colonic hyperplasia, exhibits clonality: synonymy of C. rodentium and mouse-pathogenic Escherichia coli. J Clin Microbiol (2000) 1.50
Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect Immun (2005) 1.45
Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice. Infect Immun (1999) 1.36
Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect Immun (2001) 1.34
EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect Immun (2005) 1.32
Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice. Infect Immun (2002) 1.29
Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation. Br J Pharmacol (2006) 1.18
Helminth-primed dendritic cells alter the host response to enteric bacterial infection. J Immunol (2006) 1.16
Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect Immun (2007) 1.14
Intestinal mucosal responses to microbial infection. Springer Semin Immunopathol (2005) 1.10
Citrobacter rodentium is an unstable pathogen showing evidence of significant genomic flux. PLoS Pathog (2011) 1.05
Expression of intimin gamma from enterohemorrhagic Escherichia coli in Citrobacter rodentium. Infect Immun (2000) 1.04
Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. Oncogene (2013) 1.02
A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest (2012) 1.01
A generalized transducing phage for the murine pathogen Citrobacter rodentium. Microbiology (2007) 1.00
In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med (2013) 0.99
Diarrhea as a cause of mortality in a mouse model of infectious colitis. Genome Biol (2008) 0.99
Structural and functional studies indicate that Shigella VirA is not a protease and does not directly destabilize microtubules. Biochemistry (2008) 0.96
Promoter swapping unveils the role of the Citrobacter rodentium CTS1 type VI secretion system in interbacterial competition. Appl Environ Microbiol (2012) 0.91
Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice. Infect Immun (2012) 0.89
Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization. Infect Immun (2014) 0.88
Immunocytological responses in porcine proliferative enteropathies. Infect Immun (1992) 0.88
Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes. Biomed Res Int (2012) 0.85
Citrobacter rodentium colitis evokes post-infectious hyperexcitability of mouse nociceptive colonic dorsal root ganglion neurons. J Physiol (2009) 0.83
Role of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis. Infect Immun (2014) 0.82
Non-therapeutic administration of a model antimicrobial growth promoter modulates intestinal immune responses. Gut Pathog (2011) 0.81
Isolation of Helicobacter spp. from mice with rectal prolapses. Comp Med (2014) 0.81
Differential effects of β-catenin and NF-κB interplay in the regulation of cell proliferation, inflammation and tumorigenesis in response to bacterial infection. PLoS One (2013) 0.81
Antimicrobial growth promoters modulate host responses in mice with a defined intestinal microbiota. Sci Rep (2016) 0.78
Enterocyte proliferation and intracellular bacteria in animals. Gut (1994) 0.76
Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma. PLoS One (2016) 0.76
Rapid CD8(+) Function Is Critical for Protection of Neonatal Mice from an Extracellular Bacterial Enteropathogen. Front Pediatr (2017) 0.75
Systematic analysis of two-component systems in Citrobacter rodentium reveals positive and negative roles in virulence. Infect Immun (2016) 0.75
CD40 Ligand Deficient C57BL/6 Mouse Is a Potential Surrogate Model of Human X-Linked Hyper IgM (X-HIGM) Syndrome for Characterizing Immune Responses against Pathogens. Biomed Res Int (2015) 0.75
Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane. BMC Cancer (2009) 0.75
Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science (1990) 7.33
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42
Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect Immun (1992) 3.04
Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis (1988) 3.02
Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A (1992) 2.99
Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis (1994) 2.72
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg (1992) 2.57
Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J Immunol (1992) 2.49
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun (1994) 2.42
Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity (1997) 2.38
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J Infect Dis (1991) 2.37
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
The ultrastructure of transmissible murine colonic hyperplasia. Am J Pathol (1979) 2.11
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis (1994) 2.09
The etiology of transmissible murine colonic hyperplasia. Lab Anim Sci (1976) 1.98
Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction. J Clin Microbiol (1990) 1.96
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B. Proc Natl Acad Sci U S A (1993) 1.84
Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect Immun (1998) 1.80
Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am J Trop Med Hyg (1990) 1.77
Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol (2000) 1.76
Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun (1992) 1.75
Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun (1994) 1.71
The early humoral response in human granulocytic ehrlichiosis. J Infect Dis (1997) 1.67
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64
Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol (2000) 1.63
Infectious but nonpathogenic isolate of Borrelia burgdorferi. J Clin Microbiol (1990) 1.63
An animal model for Lyme arthritis. Ann N Y Acad Sci (1988) 1.60
T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun (2000) 1.60
Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab Anim Sci (1977) 1.60
Experimental chronic Lyme borreliosis in Lewis rats. Am J Trop Med Hyg (1990) 1.59
Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice. Infect Immun (1994) 1.57
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect Immun (2000) 1.53
Pathological changes during aging in barrier-reared Fischer 344 male rats. J Gerontol (1977) 1.52
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun (1997) 1.51
Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab Anim Sci (1998) 1.51
Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Microbiol (1999) 1.50
Rapid detection of bacteremia in mice by gas chromatography. Infect Immun (1970) 1.42
Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest (1996) 1.42
Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest (1991) 1.41
In vivo studies with an "orphan" parvovirus of mice. Lab Anim Sci (1993) 1.40
Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res (1977) 1.40
Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo. J Infect Dis (1991) 1.40
OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect Immun (1993) 1.39
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37
Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein. Infect Immun (2000) 1.36
Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A (1991) 1.36
Transmissible ileal hyperplasia of hamsters. II. Ultrastructure. Am J Pathol (1978) 1.34
Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans. J Clin Microbiol (1996) 1.31
Expression and sequence of outer surface protein C among North American isolates of Borrelia burgdorferi. FEMS Microbiol Lett (1994) 1.29
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun (2001) 1.26
Mouse hepatitis virus strain--related patterns of tissue tropism in suckling mice. Arch Virol (1984) 1.25
Mycoplasma mycoides var, capri isolated from a goat in Connecticut. J Infect Dis (1969) 1.24
Characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group. J Infect Dis (1972) 1.24
Pathogenesis of sialodacryoadenitis in gnotobiotic rats. Vet Pathol (1975) 1.24
Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. J Exp Med (1993) 1.23
Gas chromatography for rapid differentiation of bacterial infections in man. Med Res Eng (1972) 1.21
Transmissible ileal hyperplasia of hamsters. I. Histogenesis and immunocytochemistry. Am J Pathol (1978) 1.20
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
The putative E5 open reading frame of cottontail rabbit papillomavirus is dispensable for papilloma formation in domestic rabbits. J Virol (1992) 1.18
An epizootic of Sendai infection with mortality in a barrier-maintained mouse colony. Am J Epidemiol (1974) 1.18
Mouse parvovirus infection potentiates allogeneic skin graft rejection and induces syngeneic graft rejection. Transplantation (1998) 1.17
CD4+ T helper 1 cells facilitate regression of murine Lyme carditis. Infect Immun (2001) 1.17
Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J Infect Dis (1998) 1.17
Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse. Infect Immun (1993) 1.17
Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol (2000) 1.16
Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J Infect Dis (1991) 1.14
Environmental stability and transmission of rat virus. Lab Anim Sci (1995) 1.12
Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob Agents Chemother (1994) 1.11
Spontaneous wasting disease in nude mice associated with Pneumocystis carinii infection. Lab Anim Sci (1986) 1.11
Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol (1996) 1.10
Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J Immunol (1997) 1.09
The academic cup: Part I. Comp Med (2000) 1.07
Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J Exp Med (1995) 1.07
The academic cup: part II. Comp Med (2000) 1.07
Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality. J Virol (1991) 1.05
The neuropathology of globoid-cell leucodystrophy in the dog. A report of two cases. Acta Neuropathol (1968) 1.04
Autoradiographic cytokinetics of colonic mucosal hyperplasia in mice. Cancer Res (1979) 1.04
Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM. Virus Res (1987) 1.03
Genetic stability of Borrelia burgdorferi recovered from chronically infected immunocompetent mice. Infect Immun (1994) 1.03
Canine neonatal deaths associated with group B streptococcal septicemia. J Am Vet Med Assoc (1983) 1.02
Age-related and light-associated retinal changes in Fischer rats. Invest Ophthalmol Vis Sci (1978) 1.02
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Infect Immun (1998) 1.02
Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation. Infect Immun (1993) 1.02
Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. J Immunol (1993) 1.01
Atypical warts in cattle. J Am Vet Med Assoc (1974) 1.01
Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue. Res Microbiol (1997) 1.01